FindTrial
Sign In

Comparison between two treatments of Cystitis that are Ela churna with Amalaki swaras and Syp.Cital with definative time period.

A Standard controlled clinical trial of Ela churna with Aamalki swarasa in management of Pittaj Mutrakrichra with special refrence to cystitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016620
Enrollment
60
Registered
2018-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N309- Cystitis, unspecified

Interventions

Intervention1: Ela churna with aamalaki swarasa: group A 30 People having pittajamutrakruchhra will be administrated with 2gm ela churna with 15ml aamalaki swaras 12 hourly for 7 days Control Interven

Sponsors

PDEAS COLLEGE OF AYURVEDA AND RESEARCH CENTRE NIGADI PUNE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with cardinal symptoms of Pittaja mutrakruchhra mentioned in yogratnakar, chapter mutrakruchhrachikitsa 1.Peethamutrata 2.Krichramutrata 3.sadahamutrata 4.saraktamutrata 5.muhurmuhurmutrata informed written consent patient having above 2 or more than complaints will be selected,

Exclusion criteria

Exclusion criteria: Obstructive pathology like BPH 1.Uncontrolled DM 2.STD,TB 3.Metabolic disorder 4.renal failure 4.chronic cystitiswith bladder wall change 5.benign or malignant tumors of bladder 6.urethral stricture 7.maleria 8.yellow fever

Design outcomes

Primary

MeasureTime frame
to compare the efficacy of ela churna with aamalaki swaras and sodium hydogen citrate in management of pittaja mutrakruchhra with special reference to cystitis. Timepoint: 3rd and 5th day—

Secondary

MeasureTime frame
1.To study the efficacy of of ela churna with aamalaki swarasa in management of pittaja mutrakruchhra wsr to cystitis. 2.To study the adverse effect if any.Timepoint: follow up on 3rd and 5th day to observe symtoms.—

Countries

India

Contacts

Public ContactDr Harshada Vaman Nemane

PDESs college of ayurved and research centre akurdi pune

drbndeshpande@gmail.com9970108596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026